Table 4.
Recurrence of Pseudomonas aeruginosa Posttraumatic Osteomyelitis Episodes by Antibiotic Therapy, Episode Type, and Length of Treatment, April 2018 to January 2022, Médecins Sans Frontières–Supported Facilities in Mosul (Iraq) and Gaza (Palestine)
| Characteristic | Total | Recurrent | Nonrecurrent | P Value |
|---|---|---|---|---|
| Antibiotic therapya, No. (%) | ||||
| Monotherapy | 36 (62.1) | 7 (53.8) | 29 (64.4) | .49 |
| Dual therapy | 22 (37.9) | 6 (46.1) | 16 (35.6) | |
| Episode typeb, No. (%) | ||||
| Monomicrobial | 14 (23.7) | 1 (7.1) | 13 (28.9) | .15 |
| Polymicrobial | 45 (76.3) | 13 (92.8) | 32 (71.1) | |
| Length of treatmentb, mean (SD) | 47.5 (15.9) | 47.5 (15.1) | 45.2 (16.3) | .63 |
Abbreviation: SD standard deviation.
aFifty-eight episodes out of 66 posttraumatic osteomyelitis caused by Pseudomonas aeruginosa (PAPTO) with complete data on recurrence (13 recurred and 45 did not recur) and antibiotic therapy were included.
bFifty-nine episodes out of 66 PAPTO with complete data on recurrence (14 recurred and 45 did not recur) and type of episode were included.